Evidence map›Paper›PMID 26232704›Full record

ArticleJournal of epidemiology and global health2016

Evaluation of medication adherence in Lebanese hypertensive patients.

Mohammad Yassine, Amal Al-Hajje, Sanaa Awada, Samar Rachidi, Salam Zein, Wafa Bawab, Mayssam Bou Zeid, Maya El Hajj, Pascale Salameh

Open access · goldAbstract read
In one paragraph

Article in Journal of epidemiology and global health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 4 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 4 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Pre-stroke Adherence to Hypertension Medications in a Bi-racial United States Stroke Belt.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mohammad YassineClinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Clinical Pharmacy Department, Doctoral School of Sciences & Technology, Lebanese University, Beirut, Lebanon.
Amal Al-HajjeClinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Clinical Pharmacy Department, Doctoral School of Sciences & Technology, Lebanese University, Beirut, Lebanon.
Sanaa AwadaClinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Clinical Pharmacy Department, Doctoral School of Sciences & Technology, Lebanese University, Beirut, Lebanon.
Samar RachidiClinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Clinical Pharmacy Department, Doctoral School of Sciences & Technology, Lebanese University, Beirut, Lebanon.
Salam ZeinClinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Clinical Pharmacy Department, Doctoral School of Sciences & Technology, Lebanese University, Beirut, Lebanon.
Wafa BawabClinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Clinical Pharmacy Department, Doctoral School of Sciences & Technology, Lebanese University, Beirut, Lebanon.
Mayssam Bou ZeidClinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Clinical Pharmacy Department, Doctoral School of Sciences & Technology, Lebanese University, Beirut, Lebanon.
Maya El HajjClinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Clinical Pharmacy Department, Doctoral School of Sciences & Technology, Lebanese University, Beirut, Lebanon.
Pascale SalamehClinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Clinical Pharmacy Department, Doctoral School of Sciences & Technology, Lebanese University, Beirut, Lebanon. Electronic address: pascalesalameh1@hotmail.com.
Lebanese University · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Controlling hypertension is essential in cardiovascular diseases. Poor medication adherence is associated with poor disease outcomes, waste of healthcare resources, and contributes to reduced blood pressure control. This study evaluates treatment adherence to antihypertensive therapy in Lebanese hypertensive patients by estimating the proportion of adherent hypertensive patients using a validated tool and investigates what factors predict this behavior. A questionnaire-based cross-sectional study was conducted on a random sample of 210 hypertensive outpatients selected from clinics located in tertiary-care hospitals and from private cardiology clinics located in Beirut. Adherence level was measured using a validated 8-item Modified Morisky Medication Adherence Scale (MMMAS). Among 210 patients, 50.5% showed high adherence, 27.1% medium adherence, and 22.4% low adherence to medication. Mean MMMAS score was 6.59±2.0. In bivariate analyses, having controlled blood pressure (p=0.003) and taking a combination drug (p=0.023) were predictors of high adherence. Forgetfulness (p<0.01), complicated drug regimen (p=0.001), and side effects (p=0.006) were predictors of low adherence after multiple liner regression. Logistic regression results showed that calcium channel blockers (p=0.030) were associated with increased adherence levels. In conclusion, developing multidisciplinary intervention programs to address the factors identified, in addition to educational strategies targeting healthcare providers, are necessary to enhance patient adherence.

Indexed as

Drug MonitoringSurveys and QuestionnairesAntihypertensive AgentsCross-Sectional StudiesFemaleHumansHypertensionLebanonMaleMiddle AgedAntihypertensive AgentsBlood pressureHypertensionLebanonMedication adherenceMorisky scale

Identifiers

PMID26232704
PMCPMC7320474
OpenAlexW1528738254

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.